Tag: FDA authorizes AstraZeneca COVID antibody treatment for emergency use

The U.S. Food and Drug Administration on Wednesday issued emergency use authorization for AstraZeneca’s Evusheld.  The vaccine maker’s COVID-19 antibody drug is for people with serious health problems or a history of allergies to a COVID-19 vaccine who are unable to get adequate protection from vaccination.  In a news release, the agency said the authorization was issued for certain adults and individuals 12…